论文部分内容阅读
目的评价艾司西酞普兰联合胃肠动力药物对伴有健康焦虑的功能性胃肠道疾病(FGID)患者的临床疗效。方法入选伴有健康焦虑的FGID患者42例,根据原先的精神用药分为黛力新组和其他精神药物组(以下简称其他组),用艾司西酞普兰取代黛力新或原来的精神治疗药物,并继续联合使用原来的胃肠动力药物进行治疗,评价患者胃肠道症状的改善情况。结果黛力新组有效率为90.5%,临床痊愈率为81.0%;其他组有效率为80.0%,临床痊愈率为60%;总有效率为85.4%,临床痊愈率为70.7%。结论艾司西酞普兰联合胃肠动力药物对伴有健康焦虑的FGID患者有较好的疗效。
Objective To evaluate the clinical efficacy of escitalopram in combination with gastrointestinal motility drugs in patients with functional gastrointestinal disease (FGID) associated with health anxiety. Methods Forty-two FGID patients with health anxiety were enrolled in this study. The patients were divided into two groups according to the psychiatric medication: Deanxit and other psychotropic substances (hereinafter referred to as the other groups), and escitalotram instead of Deanxit or the original psychiatric treatment Drugs, and continue to use the original gastrointestinal motility drug treatment, evaluation of patients with gastrointestinal symptoms improved. Results The effective rate of Deanxit was 90.5% and the clinical cure rate was 81.0%. The effective rate of other groups was 80.0%. The clinical cure rate was 60%. The total effective rate was 85.4%. The clinical cure rate was 70.7%. Conclusion Escitalopram in combination with gastrointestinal motility drugs has a good effect on FGID patients with health anxiety.